NCT03684109 Non-invasive Glioma Characterization Through Molecular Imaging
| NCT ID | NCT03684109 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Glioma |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2019-01-25 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2019-01-25 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
Eligibility Criteria
Inclusion Criteria: * Adults (≥18 year old) * Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion. Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Patients unable to have MRI done
Contact & Investigator
Macarena De La Fuente, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT03684109 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Glioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03684109 currently recruiting?
Yes, NCT03684109 is actively recruiting participants. Contact the research team at npadron@med.miami.edu for enrollment information.
Where is the NCT03684109 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT03684109 clinical trial?
NCT03684109 is sponsored by University of Miami. The principal investigator is Macarena De La Fuente, MD at University of Miami. The trial plans to enroll 30 participants.